1. Home
  2. MLYS vs USA Comparison

MLYS vs USA Comparison

Compare MLYS & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$30.19

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

USA

Liberty All-Star Equity Fund

HOLD

Current Price

$5.82

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLYS
USA
Founded
2019
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
2023
1994

Fundamental Metrics

Financial Performance
Metric
MLYS
USA
Price
$30.19
$5.82
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$48.67
N/A
AVG Volume (30 Days)
1.1M
995.7K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
37.43
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.59
$5.40
52 Week High
$47.65
$6.96

Technical Indicators

Market Signals
Indicator
MLYS
USA
Relative Strength Index (RSI) 59.06 54.03
Support Level $25.88 $5.80
Resistance Level $31.12 $5.88
Average True Range (ATR) 1.45 0.05
MACD 0.22 0.01
Stochastic Oscillator 91.67 71.75

Price Performance

Historical Comparison
MLYS
USA

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

About USA Liberty All-Star Equity Fund

Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.

Share on Social Networks: